iRhythm Technologies Stock Forecast, Price & News

+0.09 (+0.14 %)
(As of 09/21/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume331,680 shs
Average Volume629,961 shs
Market Capitalization$1.85 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

iRhythm Technologies logo

About iRhythm Technologies

iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers Zio XT, is a wearable patch-based biosensor, continuously records, and stores ECG data from every patient heartbeat for up to 14 consecutive days; and Zio AT, also provides ECG data but also provides physicians with actionable notifications during the wear period. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.


iRhythm Technologies (NASDAQ:IRTC) Shares Up 4.2%
iRhythm Technologies (NASDAQ:IRTC) Shares Up 4.2%
September 17, 2021 |
iRhythm Technologies (NASDAQ:IRTC) Sees Large Volume Increase
iRhythm Technologies (NASDAQ:IRTC) Sees Large Volume Increase
September 14, 2021 |
Noteworthy Monday Option Activity: IRTC, LULU, TDOC
Noteworthy Monday Option Activity: IRTC, LULU, TDOC
September 13, 2021 |
iRhythm Technologies (NASDAQ:IRTC) Shares Gap Up to $48.12
iRhythm Technologies (NASDAQ:IRTC) Shares Gap Up to $48.12
September 13, 2021 |
iRhythm Technologies (NASDAQ:IRTC) Trading Down 2.9%
iRhythm Technologies (NASDAQ:IRTC) Trading Down 2.9%
September 10, 2021 |
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.05 out of 5 stars

Medical Sector

507th out of 1,352 stocks

Surgical & Medical Instruments Industry

51st out of 123 stocks

Analyst Opinion: 3.1Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

iRhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

Is iRhythm Technologies a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" iRhythm Technologies stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IRTC, but not buy additional shares or sell existing shares.
View analyst ratings for iRhythm Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than iRhythm Technologies?

Wall Street analysts have given iRhythm Technologies a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iRhythm Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting iRhythm Technologies?

iRhythm Technologies saw a decline in short interest in August. As of August 13th, there was short interest totaling 1,620,000 shares, a decline of 16.1% from the July 29th total of 1,930,000 shares. Based on an average daily trading volume, of 510,100 shares, the days-to-cover ratio is currently 3.2 days. Currently, 5.6% of the company's stock are sold short.
View iRhythm Technologies' Short Interest

When is iRhythm Technologies' next earnings date?

iRhythm Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for iRhythm Technologies

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) issued its quarterly earnings results on Thursday, August, 5th. The company reported ($0.59) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.97) by $0.38. The company had revenue of $81.28 million for the quarter, compared to analysts' expectations of $72.95 million. iRhythm Technologies had a negative net margin of 19.41% and a negative trailing twelve-month return on equity of 18.41%.
View iRhythm Technologies' earnings history

How has iRhythm Technologies' stock been impacted by Coronavirus (COVID-19)?

iRhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IRTC stock has decreased by 26.5% and is now trading at $62.83.
View which stocks have been most impacted by COVID-19

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies issued an update on its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $320 million-$325 million, compared to the consensus revenue estimate of $302.33 million.

What price target have analysts set for IRTC?

11 Wall Street analysts have issued 1-year price objectives for iRhythm Technologies' shares. Their forecasts range from $55.00 to $250.00. On average, they expect iRhythm Technologies' share price to reach $147.90 in the next year. This suggests a possible upside of 135.4% from the stock's current price.
View analysts' price targets for iRhythm Technologies
or view top-rated stocks among Wall Street analysts.

Who are iRhythm Technologies' key executives?

iRhythm Technologies' management team includes the following people:
  • Douglas J. Devine, Chief Executive & Financial Officer
  • Mark J. Day, Executive Vice President-Research & Development
  • Judith Lenane, Chief Clinical Officer & Executive VP-Products
  • Allan B. Wilsker, EVP-Information Technology & Customer Services
  • David A. Vort, Executive Vice President-Sales

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies CEO Kevin M. King on Kevin M. King has an approval rating of 91% among iRhythm Technologies' employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of iRhythm Technologies' key competitors?

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), (CRM), Square (SQ), Teladoc Health (TDOC), The Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and The Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.28%), BlackRock Inc. (7.09%), Mackenzie Financial Corp (6.19%), JPMorgan Chase & Co. (4.81%), Credit Suisse AG (3.96%) and State Street Corp (2.77%). Company insiders that own iRhythm Technologies stock include David A Vort, Kevin M King, Mark J Day, Matthew C Garrett, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends for iRhythm Technologies

Which major investors are selling iRhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Macquarie Group Ltd., Wells Fargo & Company MN, Alliancebernstein L.P., New York State Common Retirement Fund, Invesco Ltd., FMR LLC, and Victory Capital Management Inc.. Company insiders that have sold iRhythm Technologies company stock in the last year include David A Vort, Kevin M King, and Mark J Day.
View insider buying and selling activity for iRhythm Technologies
or view top insider-selling stocks.

Which major investors are buying iRhythm Technologies stock?

IRTC stock was acquired by a variety of institutional investors in the last quarter, including Mackenzie Financial Corp, Point72 Asset Management L.P., JPMorgan Chase & Co., Vident Investment Advisory LLC, Fiera Capital Corp, Credit Suisse AG, Renaissance Technologies LLC, and Legal & General Group Plc.
View insider buying and selling activity for iRhythm Technologies
or or view top insider-buying stocks.

How do I buy shares of iRhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $62.83.

How much money does iRhythm Technologies make?

iRhythm Technologies has a market capitalization of $1.85 billion and generates $265.17 million in revenue each year. The company earns $-43,830,000.00 in net income (profit) each year or ($1.58) on an earnings per share basis.

How many employees does iRhythm Technologies have?

iRhythm Technologies employs 1,157 workers across the globe.

What is iRhythm Technologies' official website?

The official website for iRhythm Technologies is

Where are iRhythm Technologies' headquarters?

iRhythm Technologies is headquartered at 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at (415) 632-5700 or via email at [email protected].

This page was last updated on 9/22/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.